A new Moderna vaccine that was developed in conjunction with Trump administration’s Operation Warp Speed is nearly 95 percent effective, according to the company.
“The analysis evaluated 95 confirmed Covid-19 infections among the trial’s 30,000 participants,” CNBC reported. “Moderna, which developed its vaccine in collaboration with the National Institute of Allergy and Infectious Diseases, said 90 cases of Covid-19 were observed in the placebo group versus 5 cases observed in the group that received its two-dose vaccine. That resulted in an estimated vaccine efficacy of 94.5%.”
The news comes after the Trump’s administration’s Operation Warp Speed “awarded Moderna a $1.5 billion contract in August to ramp up manufacturing and deliver 100 million vaccine doses, enough for 50 million people,” NPR reported. “The government has an option to buy up to 400 million more doses.”
Stéphane Bancel, Chief Executive Officer of Moderna, thanked the U.S. federal government for its role in assisting the company, saying that Operation Warp Speed